Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats

Cardiometabolic syndrome occurs with obesity and consists of pathophysiological factors that increase the risk for cardiovascular events. Soluble epoxide hydrolase inhibition (sEHi) is a novel therapeutic approach that exerts renal and cardiovascular protection. Although sEHi as a therapeutic approa...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Imig, John D, Walsh, Katie A, Khan, Md Abdul Hye, Nagasawa, Tasuku, Cherian-Shaw, Mary, Shaw, Sean M, Hammock, Bruce D
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2012
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3613242/
https://ncbi.nlm.nih.gov/pubmed/23354399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1258/ebm.2012.012225
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla